This guest blog post is written by Alden Little, a Marketing Intern at Promega.
Alzheimer disease (AD) is one of the most devastating neurodegenerative disorders, affecting millions worldwide. While much attention has been given to amyloid plaques and tau tangles, emerging research suggests that metabolic dysfunction in the brain plays a crucial role in the disease’s progression. A recent study published in Acta Neuropathologica by Schröder et al. sheds new light on how astrocytes—the brain’s metabolic support cells—are affected in AD, and how their dysfunction impacts neurons.
